Strand Life Sciences Partners with Bangalore's MSCC on Head and Neck Cancer Research

The studies will include proteomics work to identify protein biomarker signatures specific to the disease with the ultimate aim of developing diagnostic or prognostic kits for use in the clinical setting.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.